Correlation Between Neuroone Medical and Bluejay Diagnostics

Can any of the company-specific risk be diversified away by investing in both Neuroone Medical and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuroone Medical and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuroone Medical Technologies and Bluejay Diagnostics, you can compare the effects of market volatilities on Neuroone Medical and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuroone Medical with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuroone Medical and Bluejay Diagnostics.

Diversification Opportunities for Neuroone Medical and Bluejay Diagnostics

0.7

Correlation Coefficient

Neuroone Medical  Bluejay Diagnostics

Poor diversification

The 3 months correlation between Neuroone and Bluejay is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Neuroone Medical Technologies and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and Neuroone Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuroone Medical Technologies are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of Neuroone Medical i.e., Neuroone Medical and Bluejay Diagnostics go up and down completely randomly.

Pair Corralation between Neuroone Medical and Bluejay Diagnostics

Given the investment horizon of 90 days Neuroone Medical Technologies is expected to generate 0.55 times more return on investment than Bluejay Diagnostics. However, Neuroone Medical Technologies is 1.81 times less risky than Bluejay Diagnostics. It trades about 0.01 of its potential returns per unit of risk. Bluejay Diagnostics is currently generating about -0.08 per unit of risk. If you would invest  144.00  in Neuroone Medical Technologies on September 22, 2024 and sell it today you would lose (68.00) from holding Neuroone Medical Technologies or give up 47.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neuroone Medical Technologies  vs.  Bluejay Diagnostics

Neuroone Medical Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuroone Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Bluejay Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly inconsistent fundamental indicators, Bluejay Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Neuroone Medical and Bluejay Diagnostics

The main advantage of trading using opposite Neuroone Medical and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuroone Medical position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.

The idea behind Neuroone Medical Technologies and Bluejay Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.